Assess lifetime risk across multiple cancer types
LumiRISKTM is a multicancer test that detects for 24 genes commonly associated with increased risk of cancer. As a single mutant gene affects the risk of cancer in several organs, LumiRISKTM‘s comprehensive coverage of 24 genes helps to identify an individual’s risks of developing cancer across multiple organs in one blood sample.
What is Risk Assessment?
Cancer risk assessment identifies individuals with a higher than average risk of developing cancer, and who may benefit from additional screening and preventive measures.
Having a mutant gene does not indicate the presence of cancer.
But it does mean you can do something about it.
Frequently Asked Questions
How does LumiRISKTM test for multiple cancer risks in one panel?
LumiRISKTM tests for a panel of 24 genes from your blood samples. Each gene in the panel is known to elevate the risk of developing one or more types of cancer in individual male and female. Hence, by covering a range of genes in one panel, we are able to provide a multi-cancer risk assessment from one blood sample.
If you are a practicing doctor in Singapore, you can order the tests with us online or call our sales hotline (+65 6592 5102). If you would like to find out more, we can schedule an appointment with you to explain our somatic and germline cancers tests in person.